Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with the Analyst / Institutional Investor over conference call on Thursday, December 9, 2021, to discuss the financial performance of the Company for the quarter and half year ended September 30, 2021 ['H1/Q2FY22']. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.
08-12-2021
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with the Analyst / Institutional Investor over conference call on Wednesday, December 8, 2021, to discuss the financial performance of the Company for the quarter and half year ended September 30, 2021 ['H1/Q2FY22']. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.
07-12-2021
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Transcript of Earnings conference call held on Wednesday, November 17, 2021 regarding the financial performance of the Company for the quarter and half year ended September 30, 2021 ['H1/Q2FY22'] We hereby enclose the Transcript of Earnings conference call held on Wednesday, November 17, 2021 regarding the financial performance of the Company for the quarter and half year ended September 30, 2021 ['H1/Q2FY22']. The above Transcript shall also be uploaded on Company's website at www.fermentabiotech.com This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.
24-11-2021

Earnings Call for Q2FY22 of Fermenta Biotech

 Conference Call with Fermenta Biotech (DIL) Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.
17-11-2021
Bigul

Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from Link Intime India Private Limited, Registrar and Transfer Agent about loss of share certificates on November 16, 2021
17-11-2021
Bigul

Fermenta Biotech Ltd - 506414 - Intimation Of Earnings Presentation For Half Year 1 / Quarter 2 - Financial Year 2021-2022 [H1/Q2 - FY22]

 Further to our intimation dated November 12, 2021, regarding approval of un-audited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and half year ended September 30, 2021, we hereby enclose a copy of Earnings Presentation for Half year 1 / Quarter 2 - Financial Year 2021-2022 [H1/Q2 - FY22]. The said Earnings Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com
15-11-2021
Bigul

Fermenta Biotech Ltd - 506414 - Publication Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2021

 Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide our letter dated November 12, 2021, regarding declaration of Un-audited Financial Results for the quarter and half year ended September 30, 2021, we are enclosing herewith photocopy of the newspaper publications published in Business Standard, Mumbai (English version) on page no. 19 and in Sakal, Mumbai (Marathi version) on page no. 7 dated November 13, 2021 for your reference and record.
15-11-2021
Bigul

Fermenta Biotech Ltd - 506414 - Related Party Transactions Under Regulation 23 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

 In connection with our earlier intimation dated November 12, 2021 regarding the Outcome of the Board Meeting for approval of the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2021, and in accordance with Regulation 23 of Listing Regulations, we are enclosing herewith the disclosure of Related Party Transactions on a consolidated basis for the half year ended September 30, 2021. This information will also be made available at https://www.fermentabiotech.com/investor_relations.php
15-11-2021
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the earnings conference call is scheduled to be held on Wednesday, November 17, 2021, to discuss the financial performance of the Company for the quarter and half year ended September 30, 2021. The invite for the said earnings conference call is enclosed herewith. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.
12-11-2021
Bigul

Fermenta Biotech Ltd - 506414 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2021 (Standalone And Consolidated)

 We write to inform you that the Board of Directors of the Company at its meeting held on November 12, 2021, has, inter alia, approved the unaudited financial results for the quarter and half year ended September 30, 2021 (Standalone and Consolidated) as enclosed. We are enclosing herewith Limited Review Reports dated November 12, 2021 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP. Kindly take the above on record. The Board meeting commenced at 3.00 p.m. and concluded at 3.55 p.m.
12-11-2021
Next Page
Close

Let's Open Free Demat Account